Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment

BACKGROUND: Mild cognitive impairment (MCI) is a syndrome characterised by a decline in cognition but relatively intact activities of daily living. People with MCI have an increased risk of developing dementia, and MCI is often referred to as a transitional stage between healthy ageing and dementia....

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner, Genevieve Z., Bensoussan, Alan, Liu, Jianxun, Hohenberg, Mark I., Chang, Dennis H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156958/
https://www.ncbi.nlm.nih.gov/pubmed/30253809
http://dx.doi.org/10.1186/s13063-018-2912-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156958/
https://www.ncbi.nlm.nih.gov/pubmed/30253809
http://dx.doi.org/10.1186/s13063-018-2912-0

Ejemplares similares